Fitbit may be getting all the attention these days, but it’s not the only mHealth company going public. Teladoc will likely follow suit in the next few days (or so), having revised its filing document with the Securities and Exchange Commission.

The telehealth service provider plans to offer 7 million shares to the public, each priced between $15 and $17, for a maximum value of $136.85 million. Furthermore, underwriters will be able to purchase 1.05 million additional shares within 30 days of the IPO.

We’re still clueless about the exact IPO date, but chances are it will come sooner rather than later. When that happens, the stock will trade on the NYSE under the ticker symbol “TDOC.”

The Dallas, TX-based company has yet to make a single dime in profit, though its customer base has been rapidly growing in recent years. Teladoc also faces competition from the likes of American Well, Doctor on Demand and MDLIVE; as well as a lawsuit from American Well, which claims Teladoc has infringed on some of its patents.

Meanwhile, the company has fought its own legal battles with the Texas Medical Board over their decision to restrict the practice of telemedicine in that state.

[Via: MedCityNews]